Our results suggest that drug resistance in tumor cells is stronger when there is a synergy of effects induced by a sufficient level of IGF-I, secreted by the microenvironment, and intimate contact between Hospicells and cancer cells. This evidence concerns the gene IGF1 and neoplasm.